ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,958, issued on May 20, was assigned to Six Peaks Bio AG (Basel, Switzerland).

"Antibodies targeting ActRIIA and ActRIIB" was invented by Christian Kunz (Basel, Switzerland), Amelie Wiederkehr (Ranspach le bas, France), Lisa Wellinger (Basel, Switzerland), Anne Laure Laine (Huningue, France), Emily Radke (West Lebanon, N.H.), Caitlin Stein (Clarkston, Mich.) and Arvind Sivasubramanian (Santa Clara, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies and antibody fragments that are specific for ActRIIA and ActRIIB. The antibodies are improved versions of bimagrumab. Antibodies of the present invention hav...